An overview of information by BASG to the novel Corona virus SARS-CoV-2 and the COVID-19 disease as well as links to websites with further information.

Up-to-date information from the 08.11.-11.11.2021 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.

Decrease in plasma donations with simultaneous increase in demand for immunoglobulins.

The Federal Office for Safety in Health Care has received an update from the European Commission regarding suspected adverse reactions to COVID-19 vaccine and the safety of SoHO.

On May 28, 2021, the use "for active immunization of individuals 12 years of age and older" was extended by the EMA.

The EMA adopted the new recommendations for the composition of seasonal influenza vaccines for the season 2021/2022 (published 30 March 2021)

National Vaccination Committee recommends extended dosage intervals for mRNA vaccines

EMA advises against ivermectin use for prevention or treatment of COVID-19 outside randomised clinical trials

The Austrian Federal Office for Safety in Health Care (BASG) informs that the temporarily put on hold batch ABV 5300 of AstraZeneca's COVID 19 vaccine has been released again and can be vaccinated.

An update on the Covid-19 convalescent plasma guidance has been provided to the Federal Office for Safety in Health Care by the European Commission.